Arch Endocrinol Metab
June 2020
Objective: Polycystic ovary syndrome (PCOS) is a recognized risk factor for nonalcoholic fatty liver disease (NAFLD). The aims of this study were to investigate the prevalence and factors associated with NAFLD in women with PCOS and evaluate noninvasive indices of hepatic fibrosis in patients with PCOS and NAFLD.
Subjects And Methods: Patients with PCOS (n = 87) and women without PCOS (n = 40; controls) were included.